MAST THERAPEUTICS INC's ticker is MSTX and the CUSIP is 576314108. A total of 38 filers reported holding MAST THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $18,000 | -80.6% | 147,852 | -86.2% | 0.00% | -100.0% |
| Q4 2016 | $93,000 | +745.5% | 1,073,104 | +954.1% | 0.00% | – |
| Q3 2016 | $11,000 | -88.5% | 101,806 | -50.4% | 0.00% | -100.0% |
| Q2 2016 | $96,000 | +255.6% | 205,188 | +110.4% | 0.00% | +100.0% |
| Q1 2016 | $27,000 | -79.2% | 97,536 | -56.6% | 0.00% | -50.0% |
| Q3 2015 | $130,000 | +1344.4% | 224,626 | +1100.3% | 0.00% | – |
| Q2 2015 | $9,000 | -59.1% | 18,714 | -57.9% | 0.00% | – |
| Q1 2015 | $22,000 | -71.4% | 44,482 | -67.7% | 0.00% | -100.0% |
| Q4 2014 | $77,000 | -56.2% | 137,908 | -56.2% | 0.00% | -66.7% |
| Q3 2014 | $176,000 | +170.8% | 314,505 | +205.3% | 0.00% | +200.0% |
| Q2 2014 | $65,000 | +160.0% | 103,005 | +78.8% | 0.00% | – |
| Q3 2013 | $25,000 | – | 57,621 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,294,934 | $599,000 | 0.42% |
| Ancora Advisors LLC | 1,234,599 | $571,000 | 0.09% |
| Alyeska Investment Group, L.P. | 1,900,000 | $1,757,000 | 0.07% |
| THOMPSON DAVIS & CO., INC. | 80,000 | $37,000 | 0.06% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,466,249 | $678,000 | 0.04% |
| SHEPHERD KAPLAN KROCHUK, LLC | 532,776 | $246,000 | 0.03% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 123,450 | $57,000 | 0.02% |
| WEXFORD CAPITAL LP | 89,360 | $41,000 | 0.00% |
| FRANKLIN RESOURCES INC | 12,046,100 | $5,570,000 | 0.00% |
| Renaissance Technologies | 1,535,000 | $710,000 | 0.00% |